Haemophilia A trial results ‘mind-blowing’

Haemophilia A trial results ‘mind-blowing’   By James Gallagher Health and science correspondent, BBC News British doctors say they have achieved “mind-blowing” results in an attempt to rid people of haemophilia A. Patients are born with a genetic defect that means they do not produce a protein needed to stop bleeding. Thirteen patients given the gene therapy at Barts Health […]

Read more

Swedish Orphan Biovitrum AB: Elocta® Approved in Kuwait for the Treatment of Haemophilia A

Swedish Orphan Biovitrum AB: Elocta® Approved in Kuwait for the Treatment of Haemophilia A STOCKHOLM–(BUSINESS WIRE)– Swedish Orphan Biovitrum AB (publ) (SOBI.ST) (Sobi™) today announces that the Ministry of Health in Kuwait has approved Elocta® (efmoroctocog alfa), a recombinant human factor VIII Fc-fusion protein with an extended half-life, for the treatment of haemophilia A. Elocta is the first recombinant factor VIII Fc […]

Read more